Chemistry Letters Vol.33, No.10 (2004)
1395
gave the adduct in poor yield, whereas the reaction gave the ad-
duct in good yield when i-propyl alcohol was used as a solvent
(Entries 1–3). The best product yield and diastereoselectivity
were obtained when the reaction was run in dichloromethane,
where syn-adduct 8a (R1 = R2 = MeO) was formed in good di-
asteromeric excess (Entry 4). Excellent yields and syn-selectiv-
ities were observed with the TBDMSO derivative 7b, although
the diasetereomeric excess of the syn-isomer was modest (Entry
5). However, the addition did not proceed with the ketene silyl
acetal derived from a glycine derivative (Entry 7). Ketene silyl
thio acetal was not employable due to the competing hydrolysis
under the reaction conditions (Entry 8). The addition product 8a
(syn:anti = 95:5) was readily transformed into the ꢀ-lactam 9 in
93% yield on treatment with i-PrMgCl in THF, and each isomer
was readily separated on silica gel TLC. Examination of the cou-
pling constant unambiguously established the relative stereo-
chemistry.9 On the basis of the diastereoselectivity, the follow-
ing transition state was proposed. The chiral imine 1 was proto-
nated with the cation-exchange resin, and the ketene silyl acetal
approached from the sterically less hindered face in an anti-per-
iplaner fashion to give the (2S,3S)-adduct 8a as a major product.
(Figure 2)
11 was transformed into the primary alcohol 14 via the following
four step sequences in excellent overall yield of 89% (m-CPBA
oxidation, HCl treatment, cleavage with HIO4, and reduction
.
with BH3 THF). Mesylation followed by removal of the PMP
group with CAN gave the known key intermediate 25,10 to 3
and 4.
In conclusion, we have developed an efficient method
for the synthesis of ꢀ-lactams substituted at the C-3 and C-4
positions in a cis-orientation using a cation-exchange resin
promoted imino aldol reaction. Using this methodology, an easy
approach was developed to a key intermediate for the synthesis
of 2-isocephem and 2-oxa-isocephem.
References and Notes
1
W. Durckheimer, J. Blumback, R. Lattrell, and K. H. Scheunemann,
Angew. Chem., Int. Ed., 24, 180 (1985); ‘‘Chemistry and Biology of
ꢀ-Lactam Antibiotics,’’ ed. by R. B. Morin and M. Gorman, Academic
Press, New York (1982), Vols. 1–3; T. Kametani, K. Fukumoto, and
M. Ihara, Heterocycles, 17, 463 (1982).
2
a) T. Fujisawa, Y. Ukaji, T. Noro, K. Date, and M. Shimizu, Tetrahe-
dron Lett., 32, 7563 (1991). b) T. Fujisawa, Y. Ukaji, T. Noro, K. Date,
and M. Shimizu, Tetrahedron, 48, 5629 (1992). c) M. Shimizu, Y.
Ukaji, J. Tanizaki, and T. Fujisawa, Chem. Lett., 1992, 1349. d) T.
Fujisawa, R. Hayakawa, and M. Shimizu, Tetrahedron Lett., 33,
7903 (1992). e) T. Fujisawa, K. Higuchi, and M. Shimizu, Synlett,
1993, 59. f) T. Fujisawa, M. Ichikawa, Y. Ukaji, and M. Shimizu,
Tetrahedron Lett., 34, 1307 (1993). g) T. Fujisawa, D. Satou, and M.
Shimizu, Bioorg. Med. Chem. Lett., 3, 2343 (1993). h) M. Shimizu,
T. Ishida and T. Fujisawa, Chem. Lett., 1994, 1403. i) T. Fujisawa,
R. Hayakawa, and M. Shimizu, Chem. Lett., 1995, 1013. j) R.
Hayakawa, I. Fuseya, T. Konagaya, M. Shimizu, and T. Fujisawa,
Chem. Lett., 1998, 49.
Transformation into a key intermediate for the synthesis of
2-isocephem and 2-oxa-isocephem was readily carried out as
shown in Scheme 1. First, the chiral auxiliary was removed on
treatment with TfOH in refluxing 2-butanone, and the resulting
methyl ketone 10 was silylated with TMSOTf/Et3N to give
the silyl enol ether 11 in quantitative yield. The silyl enol ether
3
4
a) M. Shimizu and S. Itohara, Synlett, 2000, 1828. b) M. Shimizu, S.
Itohara, and E. Hase, Chem. Commun., 2001, 2318.
PMP
PMP
H
+
N
NH
O
O
MeO
I. Ojima, I. Habus, M. Zhao, G. I. Georg, and L. R. Jayasinghe, J. Org.
Chem., 56, 1681 (1991); I. Ojima, I. Habus, M. Zhao, M. Zucco, Y. H.
Park, C. M. Sun, and T. Brigaud, Tetrahedron, 48, 6985 (1992); G. I.
Georg, Z. S. Cheruvallath, G. C. B. Harriman, M. Hepperle, and H.
Park, Bioorg. Med. Chem. Lett., 3, 2467 (1993); J. Kant, S. Huang,
H. Wong, C. Fairchild, D. Vyas, and V. Farina, Bioorg. Med. Chem.
Lett., 3, 2471 (1993); R. A. Holton and J. H. Liu, Bioorg. Med. Chem.
Lett., 3, 2475 (1993); I. Ojima, M. Zucco, O. Duclos, S. D. Kuduk,
C. M. Sun, and Y. H. Park, Bioorg. Med. Chem. Lett., 3, 2479
(1993); M. Endo and R. Droghini, Bioorg. Med. Chem. Lett., 3, 2483
(1993).
MeO
O
O
OMe
O
H
OMe
MeO
OMe
TMSO
OMe MeO
O
(2S,3S)-8a
O
OMe
OMe
OMe
H3 H4
N
MeO
H3 H4
N
MeO
O
OMe
O
(3S,4R)-9
(3S,4S)-9
PMP
O
PMP
88% JH3-H4 = 5.61 Hz
O
5% JH3-H4 = 1.95 Hz
5
D. H. R. Barton, J. Anaya, A. Gateau-Olesker, and S. D. Gero,
Tetrahedron Lett., 33, 6641 (1992).
H. Sakai, J. Synth. Org. Chem. Jpn., 39, 243 (1981).
Figure 2.
6
7
O
C. Palomo, J. M. Aizpurua, M. C. Lopez, N. Aurrekoetxea, and M.
Oiarbide, Tetrahedron Lett., 31, 6425 (1990); C. Palomo, F. P. Cossio,
J. M. Ontoria, and J. M. Odriozola, Tetrahedron Lett., 32, 3105 (1991).
A typical experimental procedure is as follows: To a suspension of
Amberlyst 15 DRY(43.0 mg, 0.2 mmol on the sulfonic acid portion,
washed EtOH and dried in vacuo at 100 ꢂC) and the imine 1 (61.9
mg, 0.2 mmol) in CH2Cl2 (1.0 mL) was added a solution of ketene silyl
acetal 7a (R1 = R2 = MeO, 96.2 mg, 0.5 mmol) in CH2Cl2 (5.0 mL) at
ꢁ78 ꢂC under an argon atmosphere. After being stirred at ꢁ78 ꢂC for
2 h, the reaction mixture was allowed to stand at room temperature
for 12 h. The suspension was filtrated through a Celite pad. The filtrate
was concentrated in vacuo to afford a crude oil. Purification on prepa-
rative silica gel TLC (n-Hex / Et2O = 1/3, as an eluent, developed
twice) gave the adduct 8a (80.2 mg, 97%) as a pale yellow oil. Exami-
nation by HPLC indicated the formation of diastereomers in a 95:5
(syn:anti) ratio and 96% de for the syn-8a.
O
O
OMe
OMe
MeO
O
MeO
TfOH
2-Butanone
Reflux, 3 h, 95%
N
N
9
8
PMP
O
PMP
10
OTMS
TMSOTf
Et3N
1) m-CPBA, CH2Cl2
0 ˚C−rt, 4 h
MeO
CH2Cl2, 78 ˚C rt
N
2) 2 M HCl, 1 h
2 h, quant.
PMP
O
11
O
O
MeO
MeO
OH
OH
HIO4 • 2H2O
THF, 0 ˚C, 4 h
MeO
N
N
PMP
PMP
O
O
12
13
BH3 •THF
MsCl, Py
OH
THF, 0 ˚C−rt, 6 h
89%, (4 steps)
N
CH2Cl2, 0 ˚C−rt, 14 h
PMP
O
70%
MeO
14
9
Determination of the absolute stereochemistry, see Ref. 2h.
23:2
MeO
ꢁ130:2 (c 0.013, CHCl3); 1H NMR (270 MHz,
CAN
OSO2Me
10 2: Yellow oil; ½ꢁꢃD
OSO2Me
PMP
MeCN, H2O
−15 ˚C, 3 h, 72%
N
CDCl3) ꢂ 3.06 (s, 3H), 3.57 (s, 3H), 4.07–4.13 (m, 1H), 4.34 (dd,
J ¼ 11:2, 7.92 Hz, 1H), 4.46 (dd, J ¼ 11:2, 4.29 Hz, 1H), 4.63–4.66
(m, 1H), 6.24 (brs, 1H); IR (CHCl3): 3187, 3015, 1722, 1457, 1344,
1194, 1168, 990, 968, 826 cmꢁ1; MS (ESI): m=z 210 ðM þ HÞþ.
N
O
H
O
2
15
Scheme 1.
Published on the web (Advance View) September 25, 2004; DOI 10.1246/cl.2004.1394